Last reviewed · How we verify
Cholates
At a glance
| Generic name | Cholates |
|---|---|
| Sponsor | Baylor Research Institute |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Quantitative Liver Function Tests Using Cholates (Phase 2)
- Validation of Different Methods for HepQuant DuO® Blood Sample Collection (N/A)
- Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124 (EARLY/Phase 1)
- Development of a Reliable Means for Functional Assessment of Liver Performance After the Fontan Operation: Dual Cholate Clearance Assay (N/A)
- Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation (NA)
- Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Passive Hepatic Congestion Secondary to Congenital Heart Disease (CHD) or Cardiomyopathy (EARLY/Phase 1)
- Evaluation of Biomarkers to Quantify Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis at Baseline and Following Bariatric Surgery (BARI) (NA)
- The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology (Phase 2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |